For decades, immortal cancer cell lines have constituted an accessible, easily usable set of biological models to investigate cancer biology and explore the potential efficacy of anticancer drugs. However, numerous studies suggest that these cell lines poorly represent the diversity, heterogeneity and drug-resistant tumors occurring in patients. The derivation and short -term culture of primary cells from solid tumors have thus gained significant importance in personalized cancer therapy. This review focuses our current understanding and the pros and cons of different methods for primary tumor cell culture. Furthermore, various culture matrices like biomimetic scaffolds, chemically defined media supplemented with essential nutrients have been prepared for different tissues. These well characterized primary tumor cells redefine cancer therapies with high translational relevance.